✦ LIBER ✦

Estrogens plus progestogen: reduced risk of CHD events?

Book ID: 120870019
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2000
Weight: 121 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200012340-00040

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estrogens plus statins beneficial for po

Estrogens plus statins beneficial for postmenopausal CHD?

📂 Article 📅 1999 🏛 Adis International Limited (now part of Wolters Kl ⚖ 231 KB

F202 Continuous oestrogen/progestogen HR

F202 Continuous oestrogen/progestogen HRT and novel mechanisms by which the risk of CHD may be reduced

✍ AIH Ahmed; AJ Proudler; D Crook; J Rymer; JC Stevenson 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Statins in the elderly: reduced risk of

Statins in the elderly: reduced risk of CHD

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB

Estrogen/progestogen: increased breast c

Estrogen/progestogen: increased breast cancer risk, lack of benefit

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 155 KB

The risk of acute myocardial infarction

The risk of acute myocardial infarction after estrogen and estrogen-progestogen replacement

✍ M Falkebom; I Persson; H-O Adami; R Bergstrom; E Eaker; H Lithell; R Mohsen; T N 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 140 KB

The effect of estrogen vs. combined estr

The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer

✍ Kueiyu Joshua Lin; Winson Y. Cheung; Jennifer Yi-Chun Lai; Edward L. Giovannucci 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 819 KB

## Abstract Studies suggest that estrogen therapy (ET) and combined estrogen‐progestogen therapy (EPT) may have different associations with colorectal cancer (CRC) risk, but data are conflicting. Prior meta‐analyses did not distinguish between ET and EPT. We conducted a meta‐analysis to summarize t